Rivus

• Residual Inflammatory Risk of Heart Failure and Atherosclerotic CVD in Diabetes: Look AHEAD Ancillary Study

  Consulting or advice, Fees or honoraria, 2 Sept 2026

• Semaglutide in Japanese participants with metabolic dysfunction-associated steatohepatitis: a subgroup analysis of the ESSENCE trial

  Shares or equity, 28 Aug 2026

• The global cardiovascular-kidney-liver-metabolic burden from 1990 to 2023

  Shares or equity, 22 Aug 2026

• Efficacy and safety of mazdutide in adults with obesity or overweight: a US-based, multicentre, phase 2, randomised, placebo-controlled clinical trial

  Consulting or advice, 21 Aug 2026

• Blood-brain barrier water permeability is elevated in type 2 diabetes and obesity: associations with cognitive function and metabolic markers

  Consulting or advice, 22 Jul 2026

Sources: pubmed.ncbi.nlm.nih.gov

• Waist-to-Height Ratio Outperforms BMI in Identifying Hepatic Steatosis and Fibrosis in U.S. Adults

  ADA Scientific Sessions 2026 abstract, 6 Jun 2026